Dan Tovar
About Dan Tovar
Dan Tovar serves as the Senior Medical Director of Oncology and Cell Therapy at Kite, a Gilead company, based in the Paris region. He has extensive experience in medical affairs and drug development, particularly in oncology and hematology, with a strong academic background in molecular oncology and clinical biology.
Work at Kite Pharma
Dan Tovar serves as the Senior Medical Director for Oncology and Cell Therapy at Kite, a Gilead company, since 2020. In this role, he focuses on advancing oncology and cell therapy initiatives in France. His responsibilities include overseeing medical strategies and ensuring the effective implementation of innovative therapies in the oncology sector.
Previous Experience at Gilead Sciences
Prior to his current position, Dan Tovar held the role of Senior Medical Director for Cell Therapy at Gilead Sciences for four months in 2018. He returned to Gilead Sciences in 2019, where he again served as Senior Medical Director for Oncology and Cell Therapy for ten months. His tenure at Gilead contributed to the development of cell therapy approaches in oncology.
Career at Janssen Inc.
Dan Tovar's career at Janssen Inc. spanned several roles, including Medical Director for Oncology and Hematology from 2015 to 2017, and Head of Medical Affairs for Hematology from 2013 to 2015. He also served as MSL Manager for Oncology-Hematology and Medical Advisor for Hematology, contributing to various medical affairs initiatives in the oncology and hematology fields.
Educational Background
Dan Tovar completed his Pharm D at the University of Toulouse from 1990 to 1996. He pursued further education at Université Paul Sabatier Toulouse III, earning a PhD in Molecular Oncology and Clinical Biology from 1998 to 2003. Additionally, he obtained an Executive MBA in Strategy, Finance, and Marketing from ESSEC Executive Education in 2017.
Research and Academic Contributions
Dan Tovar has a background in research and academia, having worked as a Scientific Researcher in Oncology-Hematology at CLCC Institut Claudius Regaud - INSERM from 2003 to 2007. He also served as an Associate Professor in Biochemistry, Molecular Biology, and Clinical Biology at Université Paul Sabatier Toulouse III during the same period, contributing to the education of future professionals in the field.